Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
The Journal of Nutritional Biochemistry|July 12, 2025
The effects of docosahexaenoic acid (DHA) on plasma cytokines, oxylipins, and tumor-infiltrating lymphocytes from women with breast cancer undergoing neoadjuvant chemotherapy in the DHA-WIN trialJaqueline Munhoz, Gilbert Bigras, Marnie Newell, et al.Heliyon|January 14, 2022
DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative TrialJudith C Hugh, Lacey S J Haddon, John Maringa Githaka, et al.International Journal of Cancer|June 9, 2025
Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double-blind, randomized controlled DHA-WIN trialJaqueline Munhoz, Marnie Newell, Gilbert Bigras, et al.BMJ Open|September 19, 2019
Comparing docosahexaenoic acid (DHA) concomitant with neoadjuvant chemotherapy versus neoadjuvant chemotherapy alone in the treatment of breast cancer (DHA WIN): protocol of a double-blind, phase II, randomised controlled trialMarnie Newell, John R Mackey, Gilbert Bigras, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 16, 2023
Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization StudyMartin D Hyrcza, Sebastiao N Martins-Filho, Alan Spatz, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 19, 2020
Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLCEmina Torlakovic, Roula Albadine, Gilbert Bigras, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|October 5, 2019
Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP)Carol C Cheung, Penny Barnes, Gilbert Bigras, et al.Lung Cancer (Amsterdam, Netherlands)|September 11, 2021
Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancerCarol C Cheung, Adam C Smith, Roula Albadine, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|May 10, 2024
Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast CancerEmina E Torlakovic, Nick Baniak, Penny J Barnes, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 7, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracyEmina Torlakovic, Hyun J Lim, Julien Adam, et al.Pageof 5